Bollard Group’s Cytosorbents Corp CTSO Stock Holding History

Bollard Group’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,801	Closed	-$31K	–	314
2022 Q1	$31K	Hold	9,801	–	–	﹤0.01%	372
2021 Q4	$41K	Hold	9,801	–	–	﹤0.01%	361
2021 Q3	$80K	Hold	9,801	–	–	﹤0.01%	304
2021 Q2	$74K	Hold	9,801	–	–	﹤0.01%	313
2021 Q1	$85K	Hold	9,801	–	–	﹤0.01%	293
2020 Q4	$78K	Hold	9,801	–	–	﹤0.01%	294
2020 Q3	$78K	Hold	9,801	–	–	﹤0.01%	278
2020 Q2	$97K	Buy	+9,801	New	+$90K	﹤0.01%	256

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group's CTSO Position: Q2 2022 in Review

Bollard Group sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 9,801 shares — an estimated $31K sold.

Bollard Group first reported a position in CTSO in Q2 2020 and held it in 8 quarters. The position peaked at $97K in Q2 2020. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Bollard Group reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Bollard Group sold 9,801 Cytosorbents Corp shares in Q2 2022, an estimated $31K.
Bollard Group first reported a position in Cytosorbents Corp in Q2 2020 and held it in 8 quarters.
Bollard Group's Cytosorbents Corp position peaked at $97K in Q2 2020.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.